Search research articles
Contact Us
Filters
Showing results (71-80 of 90) with videos related to
Page
of 9
Sort By:
Minerva Ginecologica
|
June 1, 1996
[Hysteroscopic evaluation of the endometrium in 63 postmenopausal patients treated with tamoxifen for breast cancer]
B Baldini, G L Taddei, E Tiso, et al.
Pathologica
|
September 1, 1993
[Vulval vestibular papillomatosis: anatomo-clinical study]
M G Fallani, C Penna, M Cioffi, et al.
Journal of Chemotherapy (Florence, Italy)
|
December 5, 2002
Multidrug resistance in ovarian cancer: comparing an immunocytochemical study and ATP-tumor chemosensitivity assay
M R Raspollini, P Pinzani, M Pazzagli, et al.
Pathologica
|
February 4, 2005
[BCL-2 in primary central nervous system lymphomas. Immunohistochemistry and molecular biology]
A M Buccoliero, F Castiglione, A Caldarella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 9, 2005
Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma
M R Raspollini, F Castiglione, D Rossi Degl'innocenti, et al.
Clinical Neuropathology
|
March 23, 2006
Inducible cyclooxygenase (COX-2) in glioblastoma--clinical and immunohistochemical (COX-2-VEGF) correlations
A M Buccoliero, A Caldarella, C F Gheri, et al.
Pathologica
|
January 31, 2006
[FISH and thin layer in urinary cytology]
M Paglierani, F Castiglione, F Garbini, et al.
Human Pathology
|
May 2, 2001
Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma
T Susini, D Massi, M Paglierani, et al.
Pathologica
|
May 29, 2003
[Atypical, aplastic, and unusual meningiomas. Morphology and incidence in 300 consecutive cases]
A M Buccoliero, A Caldarella, A Taddei, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 1, 2006
Expression and amplification of HER-2/neu oncogene in uterine carcinosarcomas: a marker for potential molecularly targeted treatment?
M R Raspollini, T Susini, G Amunni, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 90) with videos related to
Sort By:
Page
of 9
Minerva Ginecologica
|
June 1, 1996
[Hysteroscopic evaluation of the endometrium in 63 postmenopausal patients treated with tamoxifen for breast cancer]
B Baldini, G L Taddei, E Tiso, et al.
Pathologica
|
September 1, 1993
[Vulval vestibular papillomatosis: anatomo-clinical study]
M G Fallani, C Penna, M Cioffi, et al.
Journal of Chemotherapy (Florence, Italy)
|
December 5, 2002
Multidrug resistance in ovarian cancer: comparing an immunocytochemical study and ATP-tumor chemosensitivity assay
M R Raspollini, P Pinzani, M Pazzagli, et al.
Pathologica
|
February 4, 2005
[BCL-2 in primary central nervous system lymphomas. Immunohistochemistry and molecular biology]
A M Buccoliero, F Castiglione, A Caldarella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 9, 2005
Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma
M R Raspollini, F Castiglione, D Rossi Degl'innocenti, et al.
Clinical Neuropathology
|
March 23, 2006
Inducible cyclooxygenase (COX-2) in glioblastoma--clinical and immunohistochemical (COX-2-VEGF) correlations
A M Buccoliero, A Caldarella, C F Gheri, et al.
Pathologica
|
January 31, 2006
[FISH and thin layer in urinary cytology]
M Paglierani, F Castiglione, F Garbini, et al.
Human Pathology
|
May 2, 2001
Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma
T Susini, D Massi, M Paglierani, et al.
Pathologica
|
May 29, 2003
[Atypical, aplastic, and unusual meningiomas. Morphology and incidence in 300 consecutive cases]
A M Buccoliero, A Caldarella, A Taddei, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 1, 2006
Expression and amplification of HER-2/neu oncogene in uterine carcinosarcomas: a marker for potential molecularly targeted treatment?
M R Raspollini, T Susini, G Amunni, et al.
Page
of 9